A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 206 participants.
Also called NCT03769623
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 206 participants
- Sponsor
- Registry
-
NCT03769623
-
- Other papers using this trial's data
- Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease: The BIO-RISE CHINA Study
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03769623. Randomized; single masking; primary purpose treatment. Start 2019-06-25 (actual); primary completion 2021-02-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease
- Acronym
- Brave
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Biolimus
- Intervention (Device)
- Powerline
- Lead sponsor
- JW Medical Systems Ltd
Record details
- Record id
cardio:ct-nct03769623- Content hash
9ae6e934c8c937f5954c793191988f2a594290cefb9ecc8646ab4b4fdbf3834f